Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?
Authors
Keywords
-
Journal
SEMINARS IN NUCLEAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-08-18
DOI
10.1053/j.semnuclmed.2023.07.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
- (2023) Martin K. Bakht et al. Nature Cancer
- Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI
- (2022) Riccardo Laudicella et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
- (2022) Matthew P. Deek et al. JOURNAL OF CLINICAL ONCOLOGY
- Altered Glucose Metabolism Postchemotherapy Precedes PSMA Expression in Poorly Differentiated Prostate Cancer
- (2022) Yazan Z. Alabed CLINICAL NUCLEAR MEDICINE
- Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study
- (2022) Zhi-Bin Ke et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The prognostic role of68Ga-PSMA11 PET-based response in prostate cancer patients undergoing taxane-based chemotherapy
- (2022) Lukas Lunger et al. JOURNAL OF NUCLEAR MEDICINE
- E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
- (2021) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial
- (2021) Swayamjeet Satapathy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy
- (2021) Qaid Ahmed Shagera et al. JOURNAL OF NUCLEAR MEDICINE
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
- (2020) Ryan Phillips et al. JAMA Oncology
- Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?
- (2020) Philipp E. Hartrampf et al. Journal of Clinical Medicine
- Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer
- (2020) Angelyn Anton et al. BJU INTERNATIONAL
- Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
- (2020) Stefano Fanti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Docetaxel-Induced Interstitial Pneumonitis Detected on 68Ga-PSMA PET/CT
- (2020) Sunil Kumar et al. CLINICAL NUCLEAR MEDICINE
- Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
- (2020) Andrew J. Armstrong et al. JOURNAL OF UROLOGY
- [68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?
- (2019) Jonathan Kuten et al. EJNMMI Research
- Response assessment using [ 68 Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer
- (2019) Bernhard Grubmüller et al. PROSTATE
- Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical Response
- (2019) Nicolas Plouznikoff et al. CLINICAL NUCLEAR MEDICINE
- Proposal of Systemic Therapy Response Assessment Criteria in time of PSMA PET/CT imaging: PSMA PET Progression (PPP)
- (2019) Stefano Fanti et al. JOURNAL OF NUCLEAR MEDICINE
- Loss of PSMA Expression in Non-neuroendocrine Dedifferentiated Acinar Prostate Cancer
- (2018) Peter Bronsert et al. CLINICAL NUCLEAR MEDICINE
- Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT
- (2018) Christian Schmidkonz et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer
- (2018) Christian Schmidkonz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
- (2018) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy
- (2017) Anna Katharina Seitz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
- (2016) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
- (2012) Colleen M. Costelloe et al. Journal of Cancer
- 123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy
- (2011) S. M. Hillier et al. JOURNAL OF NUCLEAR MEDICINE
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: Implications for PSA surrogacy
- (2009) Kenji Kuroda et al. PROSTATE
- Assessing outcomes in prostate cancer clinical trials
- (2008) Gretchen A. Gignac et al. CANCER
- Imaging techniques to evaluate the response to treatment in oncology: Current standards and perspectives
- (2008) C.D. Marcus et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started